| MeSH term | MeSH ID | Detail |
|---|---|---|
| Starvation | D013217 | 47 associated lipids |
| Tuberculosis, Multidrug-Resistant | D018088 | 6 associated lipids |
Total
2
D-cycloserine
D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.
Cross Reference
Introduction
To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with D-cycloserine?
D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with D-cycloserine
PubChem Associated disorders and diseases
What pathways are associated with D-cycloserine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with D-cycloserine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with D-cycloserine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with D-cycloserine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with D-cycloserine?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with D-cycloserine?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with D-cycloserine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Grassi G and Pallanti S | Current and up-and-coming pharmacotherapy for obsessive-compulsive disorder in adults. | 2018 | Expert Opin Pharmacother | pmid:30321070 |
| Shin Y et al. | D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels. | 2018 | Drug Discov Ther | pmid:29998995 |
| Ranjan R et al. | Preparation and optimization of a dry powder for inhalation of second-line anti-tuberculosis drugs. | 2018 | Int J Pharm | pmid:29852204 |
| George SA et al. | D-Cycloserine Facilitates Reversal in an Animal Model of Post-traumatic Stress Disorder. | 2018 | Behav. Brain Res. | pmid:29580893 |
| Zhang W et al. | Determination of cycloserine in microdialysis samples using liquid chromatography-tandem mass spectrometry with benzoyl chloride derivatization. | 2018 | Biomed. Chromatogr. | pmid:29314157 |
| Sugiyama A et al. | Administration of riluzole to the basolateral amygdala facilitates fear extinction in rats. | 2018 | Behav. Brain Res. | pmid:28843863 |
| Huang CC et al. | In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates. | 2018 | J Microbiol Immunol Infect | pmid:28705770 |
| Jangra MS and Chhabra M | Cycloserine Induced Suicidal Tendencies and Kanamycin Induced Ototoxicity in Indian MDR-TB Patient: A Case Report. | 2018 | Curr Drug Saf | pmid:29866015 |
| Muller C et al. | The role of the CroR response regulator in resistance of Enterococcus faecalis to D-cycloserine is defined using an inducible receiver domain. | 2018 | Mol. Microbiol. | pmid:29205552 |
| Batson S et al. | Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine. | 2017 | Nat Commun | pmid:29208891 |
| Nakatani Y et al. | Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance. | 2017 | Antimicrob. Agents Chemother. | pmid:28971867 |
| Chen J et al. | Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis. | 2017 | J. Antimicrob. Chemother. | pmid:28961957 |
| Park S et al. | Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis. | 2017 | Respir Med | pmid:28947041 |
| Hofmeijer-Sevink MK et al. | No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial. | 2017 | J Clin Psychopharmacol | pmid:28820746 |
| Klass A et al. | d-Cycloserine facilitates extinction learning and enhances extinction-related brain activation. | 2017 | Neurobiol Learn Mem | pmid:28807795 |
| Malan-Müller S et al. | The role of microRNAs in the therapeutic action of D-cycloserine in a post-traumatic stress disorder animal model: an exploratory study. | 2017 | Psychiatr. Genet. | pmid:28574862 |
| Forsyth JK et al. | Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine. | 2017 | Schizophr Bull | pmid:28338977 |
| Baker KD and Richardson R | Pharmacological evidence that a failure to recruit NMDA receptors contributes to impaired fear extinction retention in adolescent rats. | 2017 | Neurobiol Learn Mem | pmid:27815216 |
| Na ES et al. | D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome. | 2017 | PLoS ONE | pmid:28813484 |
| Bürkner PC et al. | D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis. | 2017 | PLoS ONE | pmid:28282427 |
| Wink LK et al. | d-Cycloserine enhances durability of social skills training in autism spectrum disorder. | 2017 | Mol Autism | pmid:28138381 |
| Rismondo J et al. | Suppressor Mutations Linking gpsB with the First Committed Step of Peptidoglycan Biosynthesis in Listeria monocytogenes. | 2017 | J. Bacteriol. | pmid:27795316 |
| Goff DC | D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity. | 2017 | Curr Neuropharmacol | pmid:26915421 |
| Tremiño L et al. | Studies on cyanobacterial protein PipY shed light on structure, potential functions, and vitamin B -dependent epilepsy. | 2017 | FEBS Lett. | pmid:28914444 |
| Tabuchi F et al. | D-cycloserine increases the effectiveness of vancomycin against vancomycin-highly resistant Staphylococcus aureus. | 2017 | J. Antibiot. | pmid:28588223 |
| Sugiyama A et al. | Administration of riluzole into the basolateral amygdala has an anxiolytic-like effect and enhances recognition memory in the rat. | 2017 | Behav. Brain Res. | pmid:28359884 |
| Saitoh A et al. | Post-reexposure administration of D-cycloserine facilitates reconsolidation of contextual conditioned fear memory in rats. | 2017 | J Neural Transm (Vienna) | pmid:28275863 |
| Amorim Franco TM et al. | Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine. | 2017 | ACS Chem. Biol. | pmid:28272868 |
| Huang Y et al. | Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity. | 2017 | J. Alzheimers Dis. | pmid:28269783 |
| Li C et al. | [A preliminary study on the molecular characteristics of D-cycloserine resistance of ]. | 2017 | Zhonghua Liu Xing Bing Xue Za Zhi | pmid:28231674 |
| Mataix-Cols D et al. | D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. | 2017 | JAMA Psychiatry | pmid:28122091 |
| Tassoni R et al. | Structural and functional characterization of the alanine racemase from Streptomyces coelicolor A3(2). | 2017 | Biochem. Biophys. Res. Commun. | pmid:28042035 |
| Takiguchi K et al. | Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study. | 2017 | BMC Psychiatry | pmid:28701225 |
| Sta Maria NS et al. | D-Cycloserine Restores Experience-Dependent Neuroplasticity after Traumatic Brain Injury in the Developing Rat Brain. | 2017 | J. Neurotrauma | pmid:27931146 |
| Shimizu S et al. | Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway. | 2017 | Int J Mol Sci | pmid:28671605 |
| de Leeuw AS et al. | d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder. | 2017 | Eur. Psychiatry | pmid:27837671 |
| Sharp WG et al. | Successful pharmacotherapy for the treatment of severe feeding aversion with mechanistic insights from cross-species neuronal remodeling. | 2017 | Transl Psychiatry | pmid:28632204 |
| Yates JR et al. | Effects of N-methyl-D-aspartate receptor ligands on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting procedure. | 2017 | Psychopharmacology (Berl.) | pmid:27837332 |
| Ebrahimi C et al. | Combining D-cycloserine with appetitive extinction learning modulates amygdala activity during recall. | 2017 | Neurobiol Learn Mem | pmid:28512009 |
| Goodman J et al. | Enhancing and impairing extinction of habit memory through modulation of NMDA receptors in the dorsolateral striatum. | 2017 | Neuroscience | pmid:28377177 |
| Mao Z et al. | A simplified LC-MS/MS method for rapid determination of cycloserine in small-volume human plasma using protein precipitation coupled with dilution techniques to overcome matrix effects and its application to a pharmacokinetic study. | 2017 | Anal Bioanal Chem | pmid:28224247 |
| Sogebi OA et al. | Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy. | 2017 | Auris Nasus Larynx | pmid:27832910 |
| Olden M et al. | Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD. | 2017 | J. Nerv. Ment. Dis. | pmid:27441461 |
| McGuire JF et al. | A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission. | 2017 | J Clin Psychiatry | pmid:27314661 |
| Kim SW et al. | Low-Dose d-Cycloserine for Depression? | 2016 | J Clin Psychiatry | pmid:27561144 |
| Hofmann SG | Schrödinger's Cat and d-Cycloserine to Augment Exposure Therapy-Both Are Alive and Dead. | 2016 | JAMA Psychiatry | pmid:27367470 |
| Choi JH et al. | [Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid]. | 2016 | Korean J Gastroenterol | pmid:27206439 |
| Norrholm SD et al. | Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. | 2016 | Behav Res Ther | pmid:27183343 |
| Meuret AE et al. | The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. | 2016 | Behav Res Ther | pmid:27070526 |
| Desjardins CA et al. | Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance. | 2016 | Nat. Genet. | pmid:27064254 |
| Minshawi NF et al. | A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders. | 2016 | Mol Autism | pmid:26770664 |
| Otto MW et al. | Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions. | 2016 | Biol. Psychiatry | pmid:26520240 |
| Schade S and Paulus W | D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review. | 2016 | Int. J. Neuropsychopharmacol. | pmid:26364274 |
| Housman ST et al. | Isolation and quantitation of Clostridium difficile in aqueous and fecal matter using two types of selective media. | 2016 | J Microbiol Immunol Infect | pmid:26198865 |
| Kantrowitz JT et al. | d-Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine. | 2016 | Am J Psychiatry | pmid:27903101 |
| Rapee RM et al. | d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders. | 2016 | Behav Res Ther | pmid:27771572 |
| Hu P et al. | Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects. | 2016 | J. Neurosci. Res. | pmid:27638600 |
| Mikulka CR and Sands MS | Treatment for Krabbe's disease: Finding the combination. | 2016 | J. Neurosci. Res. | pmid:27638598 |
| Schnitzer TJ et al. | A randomized placebo-controlled pilot study of the efficacy and safety of D-cycloserine in people with chronic back pain. | 2016 | Mol Pain | pmid:27852965 |
| Ortiz V et al. | Effect of a positive reinforcing stimulus on fear memory reconsolidation in ethanol withdrawn rats: Influence of d-cycloserine. | 2016 | Behav. Brain Res. | pmid:27522017 |
| Prasad R et al. | Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis. | 2016 | Indian J Tuberc | pmid:27451820 |
| Kapolowicz MR and Thompson LT | Acute high-intensity noise induces rapid Arc protein expression but fails to rapidly change GAD expression in amygdala and hippocampus of rats: Effects of treatment with D-cycloserine. | 2016 | Hear. Res. | pmid:27702572 |
| Eniyan K et al. | Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis. | 2016 | Sci Rep | pmid:27734910 |
| Günthner J et al. | The NMDA receptor partial agonist d-cycloserine does not enhance motor learning. | 2016 | J. Psychopharmacol. (Oxford) | pmid:27436230 |
| Sartori SB et al. | Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches. | 2016 | Int. J. Neuropsychopharmacol. | pmid:26625894 |
| Liraz-Zaltsman S et al. | Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine. | 2016 | J. Mol. Neurosci. | pmid:27421842 |
| Storch EA et al. | Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial. | 2016 | JAMA Psychiatry | pmid:27367832 |
| Otto MW et al. | RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. | 2016 | Depress Anxiety | pmid:27315514 |
| Goff D | The Therapeutic Role of d-Cycloserine in Schizophrenia. | 2016 | Adv. Pharmacol. | pmid:27288073 |
| Otto MW et al. | Examining the efficacy of d-cycloserine to augment therapeutic learning in depression. | 2016 | Contemp Clin Trials | pmid:27094721 |
| Yu X et al. | Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates. | 2016 | Int. J. Tuberc. Lung Dis. | pmid:27046713 |
| Smits JA et al. | Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial. | 2016 | Contemp Clin Trials | pmid:27015966 |
| Fang A and Wilhelm S | Antidepressant use with d-Cycloserine may block fear extinction. | 2016 | Evid Based Ment Health | pmid:26792833 |
| Qiu W et al. | d-Alanine metabolism is essential for growth and biofilm formation of Streptococcus mutans. | 2016 | Mol Oral Microbiol | pmid:26526529 |
| Malan-Müller S et al. | Molecular mechanisms of D-cycloserine in facilitating fear extinction: insights from RNAseq. | 2016 | Metab Brain Dis | pmid:26400817 |
| Sierra RO et al. | Medial orbitofrontal cortex lesion prevents facilitatory effects of d-cycloserine during fear extinction. | 2016 | Behav. Brain Res. | pmid:26306827 |
| Sawant NS et al. | Neuroleptic malignant syndrome in cycloserine-induced psychosis. | 2015 May-Jun | Indian J Pharmacol | pmid:26069374 |
| Tandon VR et al. | Cycloserine induced psychosis with hepatic dysfunction. | 2015 Mar-Apr | Indian J Pharmacol | pmid:25878391 |
| Biswal I et al. | Cedecea lapagei in a patient with malignancy: Report of a rare case. | 2015 Jul-Sep | J Cancer Res Ther | pmid:26458603 |
| Kumagai T et al. | High-Level Heterologous Production of D-Cycloserine by Escherichia coli. | 2015 | Appl. Environ. Microbiol. | pmid:26341210 |
| Chaturvedi SK et al. | Unraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical Insight. | 2015 | PLoS ONE | pmid:26312749 |
| Aggarwal R et al. | XDR TB presenting as a transphyseal lytic lesion in the proximal tibia. | 2015 | BMJ Case Rep | pmid:26264953 |
| Uda N et al. | The structural and mutational analyses of O-ureido-L-serine synthase necessary for D-cycloserine biosynthesis. | 2015 | FEBS J. | pmid:26207937 |
| Lench AM et al. | Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site. | 2015 | PLoS ONE | pmid:26193112 |
| Levinson CA et al. | D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial. | 2015 | J Clin Psychiatry | pmid:26132687 |
| Iosifescu DV | Maintaining the initial clinical response after ketamine in bipolar and unipolar depression: an important next-step challenge. | 2015 | J Clin Psychiatry | pmid:26132676 |
| Kantrowitz JT et al. | Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression. | 2015 | J Clin Psychiatry | pmid:26132675 |
| Hofmann SG et al. | Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale. | 2015 | Contemp Clin Trials | pmid:26111923 |
| Lee SH et al. | Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB. | 2015 | Yonsei Med. J. | pmid:26069117 |
| Vishnoi S et al. | Modulatory effects of an NMDAR partial agonist in MK-801-induced memory impairment. | 2015 | Neuroscience | pmid:26454025 |
| Furlow B | Public outcry over US generic drug price hikes. | 2015 | Lancet Respir Med | pmid:26453140 |
| Olatunji BO et al. | EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER. | 2015 | Depress Anxiety | pmid:26372401 |
| Wu IT et al. | Amygdaloid zif268 participated in the D-cycloserine facilitation effect on the extinction of conditioned fear. | 2015 | Psychopharmacology (Berl.) | pmid:26282370 |
| Sarıdoğan GE et al. | D-Cycloserine acts via increasing the GluN1 protein expressions in the frontal cortex and decreases the avoidance and risk assessment behaviors in a rat traumatic stress model. | 2015 | Behav. Brain Res. | pmid:26225843 |
| de Kleine RA et al. | Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder. | 2015 | J Anxiety Disord | pmid:26121495 |
| Sugiyama A et al. | Systemic administration of riluzole enhances recognition memory and facilitates extinction of fear memory in rats. | 2015 | Neuropharmacology | pmid:26116528 |
| Andersson E et al. | D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial. | 2015 | JAMA Psychiatry | pmid:25970252 |
| Filippi A et al. | Electronic structure and conformational flexibility of D-cycloserine. | 2015 | Phys Chem Chem Phys | pmid:25966830 |
| Ori R et al. | Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. | 2015 | Cochrane Database Syst Rev | pmid:25957940 |
| Urbano M et al. | A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders. | 2015 | J Neuropsychiatry Clin Neurosci | pmid:25923852 |